CD4 and neoplasm: CD8+ T cells are vital effector cells in anti-tumor immunity (van der Leun et al., 2020), and the increased infiltration of CD4+ and CD8+ T cells in HNSCC tumor tissues is associated with favorable prognosis (de Ruiter et al., 2017).